ASPG and COVID-19: One of 22 patients (4.5%) had a decreased plasma asparaginase activity of < 0.1 IU/ml 18 days after the first dose of lyophilized pegaspargase in Part 2 (data during re-induction therapy assessed after receiving COVID-19 vaccine was excluded from analysis).